Greater China

China Great Wall Asset Management Corp priced a dual-tranche offering on Thursday, finding strong demand for its deal. The relatively small size and the timing of the transaction worked in favour of the bad debt manager, according to bankers.

Standard Chartered Bank (Hong Kong) is set to become the first commercial issuer of special drawing rights-denominated bonds. The group’s head of capital markets for Greater China and north Asia told GlobalRMB that the notes are testament to StanChart’s commitment to develop the renminbi markets.

In this round-up, The BRICS bank announces its lending target for the next year, two US banks compete for RMB clearing role in New York, and China Construction Bank Tokyo gets admitted to the onshore foreign exchange market. Plus, a recap of our coverage this week.

Home to the world’s largest capital market, the US has what it takes to redraw the global heat map of renminbi internationalisation (RMBi) now that it has been awarded a clearing bank and the world’s second largest RMB investment quota. Yet this potential could be squandered by the upcoming presidential elections unless market forces prevail.

Chinese property names are trickling back into the syndicated loan market, with Shui On Land becoming one of the first mid-size borrowers to access the market this year. The credit is appealing to banks on a standalone basis, but early signs show that appetite for the sector has also improved. Shruti Chaturvedi reports.

Industrial and Commercial Bank of China’s New York branch was forced to scrap a 10 year portion of a dual tranche bond on Monday because of a disagreement with investors over what it should pay. But all was not lost, as the issuer decided to make the most of the demand for the shorter tenor, taking home $1bn in the end, writes Addison Gong.

I’ve always considered myself a gent of superior taste and class. While I’m not averse to hanging out with the hoi polloi, I think it is no exaggeration to say that I’m considered one of Hong Kong’s respected elder statesmen.

China Resources Pharmaceutical Group, Samsung BioLogics and ZTO Express all have investors clamouring to join their IPOs, as they look to raise a combined $5.2bn.

Chinese data firm GDS Holdings has opened its potential $270.2m US IPO, which is expected to replicate the strong interest received by other recent listings in the country from Mainland names.

ICBC Sydney has returned to the dim sum bond market with the launch of a new two year bond.

Standard Chartered Bank (Hong Kong) has unveiled the syndicate for its special drawing rights-denominated bond.

JP Morgan is looking to sell its stake in its China joint venture with First Capital Securities, which began operations in 2011.